Valuation: MINDESTA

Market Cap 35.81L 31.31L 28.95L 26.57L 50.28L 35Cr 51.15L 3.45Cr 1.36Cr 17Cr 1.34Cr 1.32Cr 58Cr P/E 2024
-11.9x
P/E 2025 -22.2x
Enterprise Value 35.85L 31.34L 28.98L 26.59L 50.33L 35Cr 51.2L 3.46Cr 1.36Cr 17Cr 1.35Cr 1.32Cr 58Cr EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
50.43%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - -
Director TitleAgeSince
Director/Board Member 71 09/09/2014
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-1.07%-1.27%+0.95%+5.66% 4.97TCr
-2.85%-6.25%+366.61%+572.09% 3.81TCr
+1.98%+4.82%+13.71%+61.68% 3.53TCr
+1.78%+0.73%+32.68%-4.80% 3.51TCr
+0.06%+1.56%+4.41%+27.42% 2.72TCr
-3.27%-5.67% - - 1.61TCr
+1.64%+0.45%+70.86%+121.18% 1.54TCr
+0.29%+1.02%+14.95%+17.80% 1.39TCr
-1.21%+0.73%+18.02%-30.96% 1.3TCr
Average -0.29%-0.57%+65.27%+96.26% 2.71TCr
Weighted average by Cap. -0.27%-0.64%+75.95%+116.53%

Financials

2024 2025
Net sales - -
Net income -3L -2L -2L -2L -4L -2.41Cr -4L -24.12L -9L -1.18Cr -9L -9L -4.07Cr -2L -1L -1L -1L -2L -1.5Cr -2L -15.03L -6L -73.36L -6L -6L -2.53Cr
Net Debt 16.82T 14.7T 13.6T 12.48T 23.61T 16.21L 24.02T 2L 63.7T 8L 63.16T 61.77T 27.32L 3.46T 3.02T 2.79T 2.56T 4.85T 3L 4.93T 33.31T 13.08T 2L 12.97T 12.69T 6L
Logo MINDESTA
CTT Pharmaceutical Holdings, Inc. specializes in drug delivery systems technology within the pharmaceutical industry. Its technology platform includes the development of advanced oral delivery thin wafers to deliver treatment as an alternate to smoking and ingestion. The wafer is an orally administrable paper-thin polymer film used as a carrier for pharmaceutical agents. It rapidly dissolves to release the pharmaceutical agent as soon as it comes in contact with saliva, thus obviating the need for water during administration. Its oral film technology drug delivery system can be provided in various packaging configurations, ranging from unit-dose pouches to multiple-dose blister packages. Its drug delivery system technology includes nicotine, vitamins, pharmaceuticals, and many other actives. It offers oral thin strips for pain management and inflammation indications, such as arthritis. VetWafe is used for pain management for pet markets. It is a thin film for treating dogs and cats.
Employees
-